Research & Development
Bio-Techne, Oxford Nanopore Technologies to codevelop sequencing assays for reproductive health, carrier screening
Bio-Techne's Asuragen said it will leverage its PCR technology with Oxford Nanopore's any-read-length DNA sequencing capabilities to codevelop a sequencing system that identifies the most challenging yet high-prevalence carrier genes.
December 1, 2022
Aspira Women's Health, BioReference to distribute blood tests to detect the risk of ovarian malignancy
The firms will co-market and distribute Aspira's Ova1Plus, which combines its Ova1 and Overa blood tests to detect the risk of ovarian malignancy in women with adnexal masses prior to surgery.
October 5, 2022
AACC on POC tests for fertility, reproductive health
The guidance is intended to ensure that patients and their babies fully benefit from such testing, AACC said.
August 31, 2022
Fulgent launches PCR test to detect monkeypox
Fulgent, a genetic testing company focused on patient care in oncology, infectious and rare diseases, and reproductive health, will begin accepting specimens for testing next week.
August 3, 2022
Video from ASH 2021: Sickle-cell patients, activists tell their stories
It was a different story at the American Society of Hematology (ASH) 2021 meeting. The society helped alleviate the financial burden that both patients and advocates face in attending meetings. One beneficiary was Teonna Woolford, a sickle cell warrior and co-founder/CEO of advocacy group Sickle Cell Reproductive Health Education Directive.
December 19, 2021
Labcorp acquires women's digital health firm Ovia
Ovia has developed a software platform designed to help individuals manage parenting and women's and family health. It includes features like reproductive cycle tracking, baby growth tracking, and fertility and pregnancy support.
August 12, 2021
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
National hepatitis C elimination program represents an historic opportunity, according to White House
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Thermo Fisher, First Genetics to bring NGS to Russia
The partnership will allow First Genetics to market its F-Genetics NGS system and IVD assays to labs in Russia for reproductive health testing and cancer diagnostics. The F-Genetics NGS System is based on Thermo Fisher's Ion GeneStudio S5 System, according to the companies.
July 12, 2020
Celmatix takes ex-partner 23andMe to court over soured 'femtech' deal
The lawsuit was filed by Pierce Bainbridge Beck Price & Hecht in the Supreme Court of the State of New York for New York County.
December 10, 2019
Smartphones double as point-of-care diagnostics
The technical capabilities of these phones have become so advanced that they can compete with technology once thought to be only the domain of physicians' offices and hospitals. Research groups and startup companies are developing apps and technology that turn smartphones into tools that can diagnose eye disease, perform home-based urinalysis, diagnose ear infections and respiratory disease, and help women learn about their reproductive health.
December 1, 2019
Page 1 of 1